Koen van de Wetering

4.4k citations

54 papers · 3.1k indexed · h-index 32

Oncology top 2%
Molecular Biology top 10%
Genetics top 2%
Pediatrics, Perinatology and Child Health top 2%
Rheumatology top 2%

Co-authors: Piet Borst Noam Zelcer Robert S. Jansen András Váradi Alfred H. Schinkel Jos H. Beijnen Flóra Szeri Marcel de Haas
Topics: Drug Transport and Resistance Mechanisms (23 papers)Dermatological and Skeletal Disorders (22 papers)Heterotopic Ossification and Related Conditions (12 papers)
Cited by: Oncology Rheumatology Nephrology
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry Blood
Partner nations: Netherlands United States Hungary

In The Last Decade

Koen van de Wetering

53 papers receiving 3.0k citations

Peers

Countries citing papers authored by Koen van de Wetering

Since Specialization

Citations

This map shows the geographic impact of Koen van de Wetering's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koen van de Wetering with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koen van de Wetering more than expected).

Fields of papers citing papers by Koen van de Wetering

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koen van de Wetering. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koen van de Wetering. The network helps show where Koen van de Wetering may publish in the future.

Co-authorship network of co-authors of Koen van de Wetering

This figure shows the co-authorship network connecting the top 25 collaborators of Koen van de Wetering. A scholar is included among the top collaborators of Koen van de Wetering based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koen van de Wetering. Koen van de Wetering is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Loss of function mutation in Ank causes aberrant mineralization and acquisition of osteoblast-like-phenotype by the cells of the intervertebral disc 2023 ·Cell Death and Disease ·Takashi Ohnishi,(unknown),(unknown),Pranay Ramteke,William Querido,Ruteja A. Barve,Koen van de Wetering,Makarand V. Risbud	8
2	A new enzymatic assay to quantify inorganic pyrophosphate in plasma 2022 ·Analytical and Bioanalytical Chemistry ·(unknown),(unknown),Flóra Szeri,(unknown),Sharon F. Terry,Gunnar Johansson,Robert S. Jansen,Koen van de Wetering	4
3	Transcriptomics and Transposon Mutagenesis Identify Multiple Mechanisms of Resistance to the FGFR Inhibitor AZD4547 2018 ·Cancer Research ·Sjors M. Kas,Julian R. de Ruiter,Koen Schipper,Eva Schut,Lorenzo Bombardelli,Ellen Wientjens,Anne Paulien Drenth,Renske de Korte‐Grimmerink,Sunny Mahakena,Christopher Phillips,Paul Smith,Sjoerd Klarenbeek,Koen van de Wetering,Anton Berns,Lodewyk F.A. Wessels,Jos Jonkers	30
4	Negative regulation of urokinase receptor activity by a GPI-specific phospholipase C in breast cancer cells 2017 ·eLife ·(unknown),Elisa Matas-Rico,Koen van de Wetering,Daniela Leyton-Puig,Katarzyna M. Kedziora,Valentina De Lorenzi,(unknown),Bram van den Broek,Kees Jalink,Nicolai Sidénius,Anastassis Perrakis,Wouter H. Moolenaar	42
5	Abcc6 Knockout Rat Model Highlights the Role of Liver in PPi Homeostasis in Pseudoxanthoma Elasticum 2017 ·Journal of Investigative Dermatology ·Qiaoli Li,(unknown),Koen van de Wetering,(unknown),John P. Sundberg,Jouni Uitto	43
6	Functional Rescue of ABCC6 Deficiency by 4-Phenylbutyrate Therapy Reduces Dystrophic Calcification in Abcc6–/– Mice 2016 ·Journal of Investigative Dermatology ·Viola Pomozi,Christopher Brampton,Flóra Szeri,(unknown),(unknown),Koen van de Wetering,(unknown),Ludovic Martin,András Váradi,Olivier Le Saux	39
7	MRP1 mediates folate transport and antifolate sensitivity in Plasmodium falciparum 2016 ·FEBS Letters ·Sanna R. Rijpma,(unknown),Albert Bilos,Robert S. Jansen,Sunny Mahakena,Frans G. M. Rüssel,Robert W. Sauerwein,Koen van de Wetering,Jan J. Koenderink	10
8	N -lactoyl-amino acids are ubiquitous metabolites that originate from CNDP2-mediated reverse proteolysis of lactate and amino acids 2015 ·Proceedings of the National Academy of Sciences ·Robert S. Jansen,Ruben D. Addie,Remco Merkx,Alexander Fish,Sunny Mahakena,Onno B. Bleijerveld,Maarten Altelaar,Lodewijk IJlst,Ronald J. A. Wanders,Piet Borst,Koen van de Wetering	95
9	ATP-binding Cassette Subfamily C Member 5 (ABCC5) Functions as an Efflux Transporter of Glutamate Conjugates and Analogs 2015 ·Journal of Biological Chemistry ·Robert S. Jansen,Sunny Mahakena,Marcel de Haas,Piet Borst,Koen van de Wetering	52
10	Lack of ABCG2 Shortens Latency of BRCA1-Deficient Mammary Tumors and This Is Not Affected by Genistein or Resveratrol 2012 ·Cancer Prevention Research ·Serge A.L. Zander,Ariena Kersbergen,Wendy Sol,Maaike Gonggrijp,Koen van de Wetering,Jos Jonkers,Piet Borst,Sven Rottenberg	13
11	Oral Availability of Cefadroxil Depends on ABCC3 and ABCC4 2011 ·Drug Metabolism and Disposition ·Dirk R. de Waart,Koen van de Wetering,Cindy Kunne,Suzanne Duijst,Coen C. Paulusma,Ronald P.J. Oude Elferink	30
12	ABCC6 does not transport vitamin K3-glutathione conjugate from the liver: Relevance to pathomechanisms of pseudoxanthoma elasticum 2011 ·Biochemical and Biophysical Research Communications ·Krisztina Fülöp,Qiujie Jiang,Koen van de Wetering,Viola Pomozi,Pál Szabó,Tamás Arányi,Balázs Sarkadi,Piet Borst,Jouni Uitto,András Váradi	24
13	Abcc2 (Mrp2), Abcc3 (Mrp3), and Abcg2 (Bcrp1) are the main determinants for rapid elimination of methotrexate and its toxic metabolite 7-hydroxymethotrexate in vivo 2009 ·Molecular Cancer Therapeutics ·Maria L.H. Vlaming,Anita van Esch,(unknown),Els Wagenaar,Koen van de Wetering,Olaf van Tellingen,Alfred H. Schinkel	54
14	Contribution of the drug transporter ABCG2 (breast cancer resistance protein) to resistance against anticancer nucleosides 2008 ·Molecular Cancer Therapeutics ·(unknown),Robert S. Jansen,Hiroaki Yamaguchi,Marcel de Haas,Koen van de Wetering,Jan Wijnholds,Jos H. Beijnen,Piet Borst	60
15	Does the absence of ABCC6 (Multidrug Resistance Protein 6) in patients withPseudoxanthoma elasticumprevent the liver from providing sufficient vitamin K to the periphery? 2008 ·Cell Cycle ·Piet Borst,Koen van de Wetering,Reinier O. Schlingemann	57
16	Multidrug Resistance Proteins 2 and 3 Provide Alternative Routes for Hepatic Excretion of Morphine-Glucuronides 2007 ·Molecular Pharmacology ·Koen van de Wetering,Noam Zelcer,Annemieke Kuil,(unknown),M. J. X. Hillebrand,Maria L.H. Vlaming,Alfred H. Schinkel,Jos H. Beijnen,Piet Borst	82
17	Multidrug resistance-associated proteins 3, 4, and 5 2006 ·Pflügers Archiv - European Journal of Physiology ·Piet Borst,(unknown),Koen van de Wetering	237
18	MRP2 and 3 in health and disease 2006 ·Cancer Letters ·Piet Borst,Noam Zelcer,Koen van de Wetering	91
19	Mice lacking Mrp3 (Abcc3) have normal bile salt transport, but altered hepatic transport of endogenous glucuronides 2005 ·Journal of Hepatology ·Noam Zelcer,Koen van de Wetering,Rudi de Waart,George L. Scheffer,Hanns–Ulrich Marschall,Peter R. Wielinga,Annemieke Kuil,Cindy Kunne,Alexander J. Smith,Martin van der Valk,Jan Wijnholds,Ronald Oude Elferink,Piet Borst	138
20	On the putative co‐transport of drugs by multidrug resistance proteins 2005 ·FEBS Letters ·Piet Borst,Noam Zelcer,Koen van de Wetering,B. Poolman	58

About Koen van de Wetering

Koen van de Wetering is a scholar working on Rheumatology, Oncology and Genetics, having authored 54 papers that have together received 3.1k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (23 papers), Dermatological and Skeletal Disorders (22 papers) and Heterotopic Ossification and Related Conditions (12 papers). The work is most often cited by research in Oncology (1.4k citations), Rheumatology (512 citations) and Nephrology (239 citations). Koen van de Wetering has collaborated with scholars based in Netherlands, United States and Hungary. Frequent co-authors include Piet Borst, Noam Zelcer, Robert S. Jansen, András Váradi, Alfred H. Schinkel, Jos H. Beijnen, Flóra Szeri, Marcel de Haas, Sunny Mahakena and Arthur A. Bergen. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact